Fractures are among the most common clinical injuries, often requiring invasive fixation with plates, screws, or wires. While these methods work well for simple breaks, they struggle with comminuted fractures — cases where bones shatter into multiple small fragments. Restoring precise anatomy in such situations is time-consuming, often incomplete, and can leave patients with complications such as delayed healing or traumatic arthritis.
To address this challenge, researchers at Sir Run Shaw Hospital, Zhejiang University, have developed Bone-02, a novel bone adhesive inspired by the underwater grip of oysters. The material is designed to bond bone fragments quickly and securely in the body’s wet, blood-rich environment, allowing surgeons to stabilize fractures through a small incision without metal hardware.
How it Works
Bone-02 forms strong chemical bonds with bone surfaces, achieving fixation in as little as two to three minutes. Unlike metal plates, the adhesive gradually biodegrades over about six months, aligning with natural healing and eliminating the need for removal surgery. Laboratory studies show that the adhesive achieves shear strengths around 0.5 MPa and compressive strength near 10 MPa, comparable to cancellous bone.
The material’s composition draws on biomimetic principles. Similar research describes formulations of collagen combined with nanosheets and polymers that not only provide mechanical reinforcement but also help regulate inflammation, scavenge harmful molecules, and promote bone regeneration.
Early Results
In animal studies, Bone-02 enabled complete healing of rabbit fractures within eight weeks, outperforming conventional glues. Clinical trials in China have applied the adhesive in more than 150 patients. In one case, a worker with a shattered wrist bone was treated through a 2–3 cm incision: bone fragments were bonded in minutes, and after three months, healing was complete with full restoration of wrist function.
Outlook and Caution
Bone-02 appears well tolerated, with laboratory tests confirming compatibility with blood and tissues and no major safety issues reported so far. Its rapid adhesion and minimally invasive application suggest broad potential — from routine orthopedic care to emergency settings such as military operations or disaster relief.
Still, experts emphasize that larger, longer-term studies are needed to confirm safety, durability, and regulatory approval before global adoption. If validated, Bone-02 could mark a significant step toward less invasive, more efficient fracture repair, particularly for complex injuries where traditional hardware falls short.
